Package 69238-1552-9

{"route": ["ORAL"], "spl_id": "acd577e1-312c-4d5a-85b5-bc50ef9de545", "openfda": {"upc": ["0369238124897", "0369238155396", "0369238124798", "0369238155297"], "unii": ["JY0WD0UA60", "3O2T2PJ89D"], "rxcui": ["1599803", "1599805", "1805420", "1805425"], "spl_set_id": ["2335950c-be3b-4248-ad04-e9763aee47d2"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-1552-3)", "package_ndc": "69238-1552-3", "marketing_start_date": "20170201"}, {"sample": false, "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-1552-9)", "package_ndc": "69238-1552-9", "marketing_start_date": "20170201"}], "brand_name": "Memantine and Donepezil Hydrochlorides Extended-release", "product_id": "69238-1552_acd577e1-312c-4d5a-85b5-bc50ef9de545", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]", "N-methyl-D-aspartate Receptor Antagonist [EPC]", "NMDA Receptor Antagonists [MoA]"], "product_ndc": "69238-1552", "generic_name": "Memantine and Donepezil", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Memantine and Donepezil Hydrochlorides Extended-release", "active_ingredients": [{"name": "DONEPEZIL HYDROCHLORIDE", "strength": "10 mg/1"}, {"name": "MEMANTINE HYDROCHLORIDE", "strength": "7 mg/1"}], "application_number": "ANDA208328", "marketing_category": "ANDA", "marketing_start_date": "20170201", "listing_expiration_date": "20261231"}